News

CVS/pharmacy has expanded the availability of the opioid overdose reversal medicine, naloxone, in several states. The medication was already available at CVS/pharmacy without a prescription in Rhode Island

The joint research and development effort would leverage Purdue Pharma’s intellectual property and lead compounds, combined with AnaBios’ Phase-X technology. Purdue Pharma has more than 10 years of

The state-of-the-art facility provides the translational bridge between pre-clinical development and phase II clinical trials with end-to-end capabilities, including process development, cell banking, cGMP manufacturing, purification and formulation,

The companies initially focused efforts on lung diseases and will now also include kidney diseases. As part of the agreement, SGI will receive royalties and milestones from the

In the ASTRAL-1, ASTRAL-2, and ASTRAL-3 studies, 1,035 patients with genotype 1-6 HCV infection received 12 weeks of SOF/VEL. Among these patients, 21 percent had compensated cirrhosis and

The company said the drug is better than a placebo in reducing pain in patients undergoing bunionectomy. The company carried out the randomized, placebo-controlled, double-blind study in 64

The proceeds will enable Deciphera to advance its pipeline of proprietary switch control kinase inhibitors through multiple key clinical milestones. Concurrent with the financing, Liam Ratcliffe, M.D., Ph.D.,

The company carried out the worldwide Phase III RECOURSE trial in 800 patients who were earlier treated for mCRC. It met the primary efficacy endpoint of statistically significant

The US Food and Drug Administration (FDA) has approved Perrigo’s generic version of Valeant Pharmaceuticals’ BenzaClin Topical Gel. The commercial launch will start immediately. The FDA concluded that